Monopar Therapeutics (MNPR) Interest Coverage Ratio (QoQ) (2018 - 2025)
Monopar Therapeutics (MNPR) Interest Coverage Ratio (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -41.73% |
| Jun 30, 2025 | 100.00% |
| Dec 31, 2022 | 99.96% |
| Sep 30, 2022 | -2,074.97% |
| Jun 30, 2022 | 93.69% |
| Mar 31, 2022 | -148,606.84% |
| Dec 31, 2019 | 99.53% |
| Sep 30, 2019 | -62.94% |
| Jun 30, 2019 | 0.65% |
| Mar 31, 2019 | -11,227.63% |
| Dec 31, 2018 | 99.38% |
| Sep 30, 2018 | -99.99% |
| Jun 30, 2018 | -11.60% |
| Mar 31, 2018 | -5,275.65% |